IL17A and psoriasis: Moreover, IL-1R1 blockade significantly reduced the population of IL-17 A-producing γδ T cells, CD4+ T cells, and CD8+ T cells, consistent with the role of IL-1β in the development of IL-17 A-producing T cells and psoriasis pathogenesis [18–20].